Live Markets  BS Home News Now Markets & Investing Companies & Industry  Portfolio SUN 22 NOV, 2009 01:58 AM FEEDBACK 
  Live Markets* > Company Details
Get Quote Search
Stock Quote Ranbaxy Laboratories Ltd
BSE: Rs 422.45   5.15 (1.23%)
November,20 03:59
NSE: Rs 422.7   5.35 (1.28%)
November,20 03:59
Sensex
BSENSE
 
Ranbaxy Laboratories Ltd
Sector Gainers
Sector Losers
CompanyLast (Rs)Gain (%)
Titan BioTech25.7010.30
Inwinex Pharma.4.534.86
Saamya Biotech6.704.85
Natco Pharma114.204.48
Mangalam Drugs11.854.22
Welcure Drugs2.673.09
Bal Pharma26.252.94
Glenmark Pharma.254.102.94
(Source: BSE)
 more  
 Financials Results (Quarterly)
 Particulars (Rs lakh) Sep-09 Jun-09
 Sale135246109378
 Other Income12732781
 Total expenses10639184361
 Net profit1860867545
 Equity2102021020
 more  
(Source: BSE)
  Broker Calls
Report Name Broker Name Reco Price View
Ranbaxy Labs Angel Broking Neutral 280
Ranbaxy Labs Angel Broking Buy 168
Ranbaxy Labs Angel Borking Buy 188
Ranbaxy Labs Angel Broking Buy 341
Ranbaxy Labs Indiabulls Hold 504.95
Ranbaxy Labs Angel Broking Buy 475
Ranbaxy Labs Emkay Not Rated 437
Ranbaxy Labs Indiabulls Hold 538.3
Ranbaxy Labs Angel Broking Buy 487
  Returns (%) more 
Particulars BSE(%) NSE(%) 
One month9.099.11
Six months88.8988.89
One year92.2492.55
(Source: BSE)
 
BSE: 500359 | NSE: RANBAXY
 BSENSE
Open 414.00 416.00
Day High 424.00 424.75
Day Low 412.00 411.00
Previous Close 417.30 417.30
52-Week high 431.90 431.80
52-Week low 133.00 133.10
P/E 0.00 0.00
Market Cap (Rs cr) 17760.64 17769.05
Volume 300065.00 1172864.00
 Peer Group
Company Last (Rs) Mkt Cap (Rs cr)
Cipla 308.95 24013
Sun Pharma.Inds. 1437.00 29763
Biocon 267.90 5358
Cadila Health. 570.85 7792
Piramal Health 400.85 8378
Glenmark Pharma. 254.10 6368
(Source: BSE)
 Company Profile - Ranbaxy Labs.
Profile
Chairman: Tejendra Khanna
Site Url: www.ranbaxy.com
Company Address
A-11 Industrial Area
Sahibzada Ajit Singh Nagar
Ropar
 
  Ranbaxy Labs. News more 
Ranbaxy recalls drug in US
Ranbaxy finding ways to make two of four acquisitions work
Ranbaxy Labs reports net profit of Rs 116 cr
Ranbaxy wins US court ruling on Roche patent
Daiichi signs marketing deal for Mexico with Ranbaxy
SC pulls up Ranbaxy for delayed raising of refund issue
Ranbaxy cuts pay package for new chief
  Performance & Analysis more 
ParticularsBSENSE
EPS (Trailing 12 mnths,Rs)-17.19-17.19
Free Float (%)36.0836.08
FII holding 5.015.01
ROCE(%)0.000.00
Face Value (in Rs) 5.00
  Shareholding Pattern more 
ParticularsMar-08Dec-07
Indian promoters34.2434.25
Foreign promoters--
Acting person--
Other promoters0.580.58
MFs/UTI3.035.07
Banks/FIs20.3120.15
FIIs17.9513.95
Public corporate bodies2.343.04
Indian public18.5319.67
NRIs/OCBs--
Others0.370.39
No of shares373153659373070829
(Source: BSE)
  
Quick Links
Market News Commodities News
Top Gainers Top Losers
52 Week High 52 Week Low
The Smart Investor Broker calls
BSE Notices IPO
 
Stock Name A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
 
Business Standard Network:  Business Standard.com | BSmotoring.com | BShindi.com | E-paper | Portfolios
ABOUT US PARTNER WITH US JOBS@BS ADVERTISE WITH US TERMS & CONDITIONS SITE MAP CONTACT US
Business Standard Ltd. Copyright & Disclaimer feedback@business-standard.com
This site is best viewed with Internet Explorer 6.0 or higher; Firefox 2.0 or higher at a minimum screen resolution of 1024x768
* Stock quotes delayed by 10 minutes or more. All information provided is on "as is" basis and for information purposes only. Kindly consult your financial advisor or stock broker to verify the accuracy and recency of all the information prior to taking any investment decision. While due diligence is done and care taken prior to uploading the stock price data, neither Business Standard Limited, www.business-standard.com nor any independent service provider is/are liable for any information errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.